drugset / Trial / NCT01144728

Initiation and Titration of Amaryl

NCT01144728

Phase 4 Completed 172 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

Primary Objective: * To describe the conditions of initiation and titration of Amaryl M, according to previous treatment: * initial dose * titration scheme * efficacy after 4 months assessed by HbA1C * tolerability (number and severity of hypoglycaemia) Secondary Objective: * Fasting Plasma Glucose * Weight evolution

Timeline

Start
2010-05
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule 1 mg Oral
Subject Glimepiride Small molecule 2 mg Oral
Subject Metformin Small molecule 250 mg Oral
Subject Metformin Small molecule 500 mg Oral